Fact check
“BAXFENDY (baxdrostat) is a new FDA‑approved prescription medicine that lowers blood pressure by directly targeting aldosterone.”
Reasoning
The CBS News video excerpts describe BAXFENDY® (baxdrostat) as a newly FDA‑approved prescription drug used with other antihypertensives to treat high blood pressure in adults, and they specify its mechanism as direct targeting of the hormone aldosterone. This directly corroborates each element of the claim.
On confidence: Both provided excerpts explicitly state that BAXFENDY (baxdrostat) is an FDA‑approved prescription medicine that lowers blood pressure by directly targeting aldosterone.
Important context
The evidence comes from a CBS News segment featuring Dr. Dmitry Yaranov, an AstraZeneca brand partner, and includes a reference to the product's prescribing information.
Evidence
Supporting (2)
- Tier 1 — Primary sourceDid you know a hormone could be why blood pressure stays high? - CBS News
to talk about the blood pressure hormone, aldosterone, that could be an underlying factor in keeping blood pressure high. Dr. Yaranov also talks about a new FDA-approved prescription medicine called BAXFENDY® (baxdrostat) that lowers blood…
- Tier 1 — Primary sourceDid you know a hormone could be why blood pressure stays high? - CBS News
Did you know a hormone could be why blood pressure stays high? - CBS News Watch CBS News Can a hormone keep your blood pressure high? Please see full Prescribing Information, including Patient Information:…
Limitations
The sources are promotional (sponsored by AstraZeneca) and not independent regulatory documents; however, they directly quote the FDA‑approval status and mechanism, which is sufficient for verification of the claim as presented. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Sep 30, 2026, 5:38 PM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual